Navigation Links
AMRI Announces First Quarter 2013 Results and Raises EPS Guidance for the Year
Date:5/7/2013

f certain amphetamine salts sold by Actavis.
Net income under U.S. GAAP was $6.5 million, or $0.21 per basic and diluted share, in the first quarter of 2013, compared to a U.S. GAAP net loss of $(3.8) million, or $(0.13) per basic and diluted share for the first quarter of 2012. Net income on an adjusted basis in the first quarter of 2013 was $7.2 million or $0.23 per diluted share. The adjustments to U.S. GAAP net income primarily relate to restructuring charges of approximately $0.6 million, net of tax, or $0.02 per diluted share, related to the company's previously announced decision to close its Bothell, WA facility.

For a reconciliation of U.S. GAAP net income (loss) and earnings (loss) per diluted share as reported to adjusted net income (loss) and earnings (loss) per diluted share for the 2013 and 2012 reporting periods, please see Table 1 at the end of this press release.

AMRI Chairman, President and CEO Thomas E. D'Ambra said, "We are pleased to report first quarter results for 2013 that reflect contract margin improvements driven by the performance in our Discovery and Large Scale Manufacturing businesses. Our overall performance for the first quarter of 2013 reaffirms the consistent and positive direction of our company. We continue to build global relationships to drive value for our shareholders as evidenced by the recently signed agreements with Ono Pharmaceutical Company, Ltd. for drug discovery and development services and a specialty pharmaceutical company for various services for multiple oncology products. We are marking the first year anniversary of the roll out of AMRI SMARTSOURCING™, an industry leading move to strategic decision making and the true measurement of success in outsourcing for drug discovery, development and manufacturing. These financial results demonstrate that our customers understand the importance of making smart choices about
'/>"/>

SOURCE AMRI
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Rigel Announces First Quarter 2013 Financial Results
2. Mindray Announces First Quarter 2013 Financial Results
3. Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery
4. Hologic Announces Second Quarter Fiscal 2013 Operating Results
5. Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer
6. AG Mednet Announces Partnership with The Methodist DeBakey Heart & Vascular Center Echocardiography Core Lab
7. Isis Pharmaceuticals Announces the Initiation of a Clinical Study of ISIS-STAT3 Rx in Patients with Liver Cancer
8. Apollo Medical Holdings Announces Record Fiscal Year-End Results
9. Atrium Medical Announces 1-year results of the INFUSE-AMI Trial
10. Premier Home Medical Supply Vendor Med Supply Shop Announces Drive Spring Promotion
11. Volcano Announces First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... LAWRENCEVILLE, N.J. , July 31, 2014  Celsion ... the Company will host a conference call to discuss ... EDT on Thursday, August 7, 2014. To participate in ... North America ) or 1-785-830-1924 (International/Toll) and ask ... (Conference Code: 8283269) to register ten minutes before the ...
(Date:7/31/2014)... , 31. Juli 2014 Marken ... Miami bekanntgegeben, um die wachsenden ... und Lateinamerika zu erfüllen. Die neu ausgebaute Einrichtung ... Proben und für die Zusammenlegung von Sendungen in ... zusätzliche Lagerkapazität bereitstellen.   Logo - ...
(Date:7/31/2014)... LAVAL, Quebec, July 31, 2014   , 2014 ... over the prior year , Overall organic growth was 4% ... facial injectable products; Bausch + Lomb grew 12% , ... increase of 43% , 2014 Second Quarter GAAP Operating ... , Highlights of the Second Quarter , Launched ...
Breaking Medicine Technology:Celsion Corporation to Hold Second Quarter 2014 Financial Results 2Marken erweitert regionales Logistikzentrum in Miami 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 3Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 4Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 5Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 6Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 7Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 8Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 9Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 10Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 11Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 12Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 13Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 14Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 15Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 16Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 17Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 18Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 19Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 20Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 21Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 22Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 23Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 24Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 25Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 26Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 27Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 28Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 29Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 30Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 31Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 32
... June 14, 2011 /PRNewswire-iReach/ -- URINOZINC® ... (Photo:   http://photos.prnewswire.com/prnh/20110614/CG20097 ) ... available at all corporate-owned GNC Live Well stores ... 1935, GNC has more than 6,000 stores spread ...
... Watson Pharmaceuticals, Inc. (NYSE: WPI ) ... filed an Abbreviated New Drug Application (ANDA) with ... approval to market Olopatadine Hydrochloride Ophthalmic Solution USP, ... is a generic version of Alcon, Inc.,s Pataday™ ...
Cached Medicine Technology:Patented URINOZINC® Prostate Formula Now Available at GNC Stores 2Patented URINOZINC® Prostate Formula Now Available at GNC Stores 3Watson Confirms Pataday™ Patent Challenge 2Watson Confirms Pataday™ Patent Challenge 3
(Date:7/31/2014)... (PRWEB) July 31, 2014 Ticket Down ... at Levi’s Stadium in Santa Clara, California. Fans in the ... see some of the best club and national teams in the ... to Brazil, this has become the best time to be a ... and special events being held on American soil this year, as ...
(Date:7/31/2014)... 2014 David Kekich, anti-aging icon ... ) is thrilled that the acceptance of his ... Artificial Intelligence (AI) algorithms and then screening thousands ... acceptance. , “It took longer than ... proof is in," said Kekich. "Client acceptance is ...
(Date:7/31/2014)... July 31, 2014 Much of the liver,s metabolic ... body clock and UC Irvine researchers have now ... The study, published online today in Cell , ... metabolism and points the way to more focused drug ... obesity and diabetes. , Paolo Sassone-Corsi, UCI,s Donald Bren ...
(Date:7/31/2014)... July 31, 2014 BioProcess ... delivering cutting-edge information focused on the development ... launched its newly designed website, http://www.bioprocessintl.com ... by providing visitors specialized content under upstream ... business areas. As the site is updated ...
(Date:7/31/2014)... -- Many teens never outgrow their "growing pains," according ... for years, affecting teens, participation in sports and other ... growing pains can become chronic, the researchers cautioned. ... three young people between the ages of 12 and ... Michael Skovdal Rathleff, a physiotherapist from Aarhus University. "Seven ...
Breaking Medicine News(10 mins):Health News:Mexico vs. Chile Tickets Levi’s Stadium: Ticket Down Slashes Ticket Prices for Chile vs. Mexico at Levi’s Stadium in Santa Clara, California on September 6th 2Health News:Mexico vs. Chile Tickets Levi’s Stadium: Ticket Down Slashes Ticket Prices for Chile vs. Mexico at Levi’s Stadium in Santa Clara, California on September 6th 3Health News:MaxLife Solution™ Expands Distribution Globally for Breakthrough Anti-Inflammatory Support Supplement – InflaGene™ 2Health News:Strict genomic partitioning by biological clock separates key metabolic functions 2Health News:BioProcess International Launches New Website 2Health News:Teen 'Growing Pains' May Persist For Years 2
... University of Southern ... Angeles County Hospital, STEINBACH, Manitoba, Feb. 4 Partnered ... of Santa Monica, MCM,served as the millwork provider for the ... highly detailed work involving a large,number of custom nursing stations ...
... MCM,s Biggest Project Completed With Detailed Precision, ... a joint,venture of Pei Architects and Perkins & ... replacement hospital in Westwood, the Ronald,Reagan UCLA Medical ... Angeles,California. Featuring over 70,000 square feet of wall ...
... deficits , , MONDAY, Feb. 4 (HealthDay News) -- Eye ... during pregnancy but who don,t have the distinctive facial ... suggests. , "Eyeblink conditioning (EBC) is a Pavlovian ... such as a tone, with an unconditioned stimulus, such ...
... Renowned esthetician, Karen,Dunlap, has developed an advanced ... the number-one most nutritious and powerful food,in the ... between science and,nature, Dunlap discovered that topical application ... its benefits. Her new signature facial, the,Acai Berry ...
... Progen,Pharmaceuticals, Management Team (ASX: PGL; Nasdaq: PGLA) will ... 9.00am,Australian (Sydney time) and Monday 4 February at 5:00pm ... overview of the Cellgate, Inc.,acquisition and will be available ... refer to the relevant presentation at: http://www.progen-pharma.com , ...
... Trust for America,s,Health warns that the proposed 7 percent ... (CDC) in the president,s fiscal year 2009,budget could harm ... CDC would fall to a six year low for ... are skyrocketing, we should be,investing more to keep Americans ...
Cached Medicine News:Health News:MCM Completes LAC+USC Replacement Medical Facility Project 2Health News:Eye Blinks May ID Fetal Alcohol Exposure 2Health News:Breakthrough 'Acai Berry Anti-Aging Facial' Applies Benefits of Nature's Super-Food to the Skin 2Health News:Progen Investor Teleconference Dial In Details 2Health News:Cuts to HHS Could Leave Americans' Health in Critical Condition, TFAH Says; New Poll Shows Americans Believe Disease Prevention is Key to Reducing Healthcare Costs 2
... The iCycler thermal cycler maximizes what ... laboratory. It features multiple sample formats, an ... direct upgradability to real-time quantitative PCR. The ... of what a thermal cycler can do ...
... small footprint, simple intuitive programming and almost ... the ideal personal cycler in the modern ... and the self-adjusting heated lid allows a ... vessels or a microplate of 5 x ...
... The system includes: Mx3005P instrument ... choice of five (5) filters. The ... I (492nm-516nm), HEX/JOE/VIC (535nm-555nm), ROX/Texas Red ... Also included: desktop computer, Mx3005P analysis ...
... The SmartCycler System is a rapid, real-time ... prepared biological samples. By automating much of ... site individually programmable, it is the fastest, ... now on the market. The SmartCycler delivers ...
Medicine Products: